Literature DB >> 10545431

Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome.

R Mehran1, G Dangas, A S Abizaid, G S Mintz, A J Lansky, L F Satler, A D Pichard, K M Kent, G W Stone, M B Leon.   

Abstract

BACKGROUND: The angiographic presentation of in-stent restenosis (ISR) may convey prognostic information on subsequent target vessel revascularizations (TLR). METHODS AND
RESULTS: We developed an angiographic classification of ISR according to the geographic distribution of intimal hyperplasia in reference to the implanted stent. Pattern I includes focal (< or =10 mm in length) lesions, pattern II is ISR>10 mm within the stent, pattern III includes ISR>10 mm extending outside the stent, and pattern IV is totally occluded ISR. We classified a total of 288 ISR lesions in 245 patients and verified the angiographic accuracy of the classification by intravascular ultrasound. Pattern I was found in 42% of patients, pattern II in 21%, pattern III in 30%, and pattern IV in 7%. Previously recurrent ISR was more frequent with increasing grades of classification (9%, 20%, 34%, and 50% for classes I to IV, respectively; P=0.0001), as was diabetes (28%, 32%, 39%, and 48% in classes I to IV, respectively; P<0.01). Angioplasty and stenting were used predominantly in classes I and II, whereas classes III and IV were treated with atheroablation. Final diameter stenosis ranged between 21% and 28% (P=NS among ISR patterns). TLR increased with increasing ISR class; it was 19%, 35%, 50%, and 83% in classes I to IV, respectively (P<0.001). Multivariate analysis showed that diabetes (odds ratio, 2.8), previously recurrent ISR (odds ratio, 2. 7), and ISR class (odds ratio, 1.7) were independent predictors of TLR.
CONCLUSIONS: The introduced angiographic classification is prognostically important, and it may be used for appropriate and early patient triage for clinical and investigational purposes.

Entities:  

Mesh:

Year:  1999        PMID: 10545431     DOI: 10.1161/01.cir.100.18.1872

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  146 in total

Review 1.  New recipes for in-stent restenosis: cut, grate, roast, or sandwich the neointima?

Authors:  C Di Mario; F Marsico; M Adamian; E Karvouni; R Albiero; A Colombo
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

2.  Histopathology of coronary in-stent restenosis following gamma brachytherapy.

Authors:  H C Lowe; M Mino; E J Mark; B D Mac Neill; I F Palacios; S L Houser
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

Review 3.  Drug-eluting stents for cardiovascular disorders.

Authors:  Juan F Granada; Grzegorz L Kaluza; Albert Raizner
Journal:  Curr Atheroscler Rep       Date:  2003-07       Impact factor: 5.113

4.  Everolimus-eluting stents for treatment of chronic total coronary occlusions.

Authors:  Jochen Wöhrle; Wolfgang Rottbauer; Armin Imhof
Journal:  Clin Res Cardiol       Date:  2011-09-22       Impact factor: 5.460

5.  Long-term angiographic outcomes of post-sirolimus-eluting stent restenosis in Japanese patients.

Authors:  Nobuyuki Miyai; Noriyuki Kinoshita; Keisuke Oota; Takeshi Yamada; Reo Nakamura; Hidekazu Irie; Tetsuo Hashimoto; Shyunichi Tamaki; Hiroaki Matsubara
Journal:  Heart Vessels       Date:  2010-10-27       Impact factor: 2.037

Review 6.  New approaches to preventing restenosis.

Authors:  Balram Bhargava; Ganesan Karthikeyan; Alexandre S Abizaid; Roxana Mehran
Journal:  BMJ       Date:  2003-08-02

7.  Evaluation of in-stent neointimal tissue components using integrated backscatter intravascular ultrasound: comparison of drug-eluting stents and bare-metal stents.

Authors:  Yoshitaka Muraoka; Shinjo Sonoda; Kuninobu Kashiyama; Fumihiko Kamezaki; Yuki Tsuda; Masaru Araki; Masahiro Okazaki; Yutaka Otsuji
Journal:  Int J Cardiovasc Imaging       Date:  2011-12-18       Impact factor: 2.357

8.  Diagnostic value of myocardial SPECT to detect in-stent restenosis after drug-eluting stent implantation.

Authors:  Hyo Eun Park; Bon-Kwon Koo; Kyung-Woo Park; Jin Chul Paeng; Hae-Young Lee; Hyun-Jae Kang; Hyo-Soo Kim
Journal:  Int J Cardiovasc Imaging       Date:  2012-03-07       Impact factor: 2.357

Review 9.  Restenosis after PCI. Part 2: prevention and therapy.

Authors:  J Wouter Jukema; Tarek A N Ahmed; Jeffrey J W Verschuren; Paul H A Quax
Journal:  Nat Rev Cardiol       Date:  2011-10-11       Impact factor: 32.419

10.  Bow hunter's stroke due to prominent degenerative spinal disorder.

Authors:  L Andereggen; M Arnold; R H Andres; A Raabe; M Reinert; J Gralla
Journal:  Clin Neuroradiol       Date:  2012-06-12       Impact factor: 3.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.